1. Home
  2. ZLAB vs BRC Comparison

ZLAB vs BRC Comparison

Compare ZLAB & BRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • BRC
  • Stock Information
  • Founded
  • ZLAB 2013
  • BRC 1914
  • Country
  • ZLAB China
  • BRC United States
  • Employees
  • ZLAB N/A
  • BRC N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • BRC Miscellaneous manufacturing industries
  • Sector
  • ZLAB Health Care
  • BRC Consumer Discretionary
  • Exchange
  • ZLAB Nasdaq
  • BRC Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • BRC 3.3B
  • IPO Year
  • ZLAB 2017
  • BRC 1984
  • Fundamental
  • Price
  • ZLAB $34.55
  • BRC $66.65
  • Analyst Decision
  • ZLAB Buy
  • BRC
  • Analyst Count
  • ZLAB 4
  • BRC 0
  • Target Price
  • ZLAB $47.37
  • BRC N/A
  • AVG Volume (30 Days)
  • ZLAB 1.0M
  • BRC 212.8K
  • Earning Date
  • ZLAB 08-05-2025
  • BRC 05-16-2025
  • Dividend Yield
  • ZLAB N/A
  • BRC 1.45%
  • EPS Growth
  • ZLAB N/A
  • BRC 3.35
  • EPS
  • ZLAB N/A
  • BRC 4.03
  • Revenue
  • ZLAB $418,326,000.00
  • BRC $1,459,732,000.00
  • Revenue This Year
  • ZLAB $44.07
  • BRC $13.02
  • Revenue Next Year
  • ZLAB $49.13
  • BRC $3.76
  • P/E Ratio
  • ZLAB N/A
  • BRC $16.68
  • Revenue Growth
  • ZLAB 43.72
  • BRC 8.62
  • 52 Week Low
  • ZLAB $16.01
  • BRC $62.70
  • 52 Week High
  • ZLAB $44.34
  • BRC $77.68
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 49.05
  • BRC 34.45
  • Support Level
  • ZLAB $36.36
  • BRC $66.70
  • Resistance Level
  • ZLAB $44.34
  • BRC $68.78
  • Average True Range (ATR)
  • ZLAB 1.45
  • BRC 1.26
  • MACD
  • ZLAB -0.16
  • BRC -0.33
  • Stochastic Oscillator
  • ZLAB 39.20
  • BRC 16.98

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About BRC Brady Corporation

Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.

Share on Social Networks: